Taro Pharmaceutical Industries Ltd

D. E. Shaw & Co., Inc.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

10,345

Value ($000)

432

Weight

0.0%

2013 Q4 - 2023 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	432	0.0%	10,345	12/31/2023
2023 Q3	11/14/2023	376	0.0%	9,978	9/30/2023
2023 Q2	8/14/2023	1,292	0.0%	34,066	6/30/2023
2023 Q1	5/15/2023	1,306	0.0%	53,694	3/31/2023
2022 Q4	2/14/2023	1,616	0.0%	55,652	12/31/2022
2022 Q3	11/14/2022	1,656	0.0%	55,249	9/30/2022
2022 Q2	8/15/2022	2,091	0.0%	57,832	6/30/2022
2022 Q1	5/16/2022	2,559	0.0%	59,145	3/31/2022
2021 Q4	2/14/2022	2,806	0.0%	56,001	12/31/2021
2021 Q3	11/15/2021	3,767	0.0%	59,196	9/30/2021
2021 Q2	8/16/2021	4,486	0.0%	62,344	6/30/2021
2021 Q1	5/17/2021	4,928	0.0%	66,815	3/31/2021
2020 Q4	2/16/2021	5,699	0.0%	77,624	12/31/2020
2020 Q3	11/16/2020	4,498	0.0%	82,010	9/30/2020
2020 Q2	8/14/2020	5,690	0.0%	85,576	6/30/2020
2020 Q1	5/15/2020	5,298	0.0%	86,560	3/31/2020
2019 Q4	2/14/2020	8,106	0.0%	92,196	12/31/2019
2013 Q4	2/14/2014	2,458	0.0%	24,852	12/31/2013